학술논문
Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials
Document Type
Article
Author
Source
In: Translational Lung Cancer Research . (Translational Lung Cancer Research, June 2022, 11(6):953-963)
Subject
Language
English
ISSN
22264477
22186751
22186751